GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background

Published:2020-05-15 Issue:7 Volume:46 Page:226-233
ISSN:0190-2148
Container-title:Experimental Lung Research
language:en
Short-container-title:Experimental Lung Research

Author:

Er Jin¹,Chao Li²,Yiwei Li¹,Feng Xing³,Fei Zhao¹,Kan Wu⁴,Ruifei Xie²

Affiliation:

1. Department of Respiratory Medicine, Hangzhou, Zhejiang, China;

2. Center for Molecular Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China;

3. Department of Thoracic Surgery, Hangzhou, Zhejiang, China;

4. Medical Oncology, Affiliated Hangzhou First People ‘s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01902148.2020.1764667

Reference27 articles.

1. Molecular Cloning and Characterization of a Novel Retinoic Acid-inducible Gene That Encodes a Putative G Protein-coupled Receptor

2. Molecular evolution of a chordate specific family of G protein-coupled receptors

3. Integrative Genomics Revealed RAI3 Is a Cell Growth-promoting Gene and a Novel P53 Transcriptional Target

4. Identification of the Retinoic Acid-Inducible Gprc5a As a New Lung Tumor Suppressor Gene

5. Normal Lung Development in RAIG1-Deficient Mice Despite Unique Lung Epithelium–Specific Expression

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPRC5A promotes paclitaxel resistance and glucose content in NSCLC;Anti-Cancer Drugs;2024-04-08

2. Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer;2022-10-28

3. Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma;Cancer Research;2022-03-15

4. Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications;Cancer Research;2022-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3